Latest Regulatory Approval News

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

Alligator Energy has secured final regulatory approval to begin its in-situ Field Recovery Trial at the Samphire Uranium Project, advancing the development of its recently upgraded Blackbush Deposit resource.

Santos Limited reports a 31% drop in net profit for H1 2025 despite increased sales volumes and progress on key projects, while receiving a non-binding acquisition proposal from an Abu Dhabi-led consortium.

Haranga Resources has secured regulatory approvals and begun underground works at its Lincoln Gold Project, setting the stage for a maiden drilling campaign aimed at upgrading a significant historical gold resource to JORC standards.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Piedmont Lithium Inc. has halted trading on the ASX as it finalises a merger with Sayona Mining Limited, marking a significant restructuring in the lithium mining sector.

Endeavour Group reported a slight revenue decline and a 16% drop in profit for FY25, alongside significant leadership changes including the appointment of a new CEO. The company is advancing its technology separation and sustainability initiatives while maintaining dividend payments.

Enterprise Metals is set to begin air core drilling at its Murchison Project targeting rare earth elements, following regulatory approval and a heritage agreement. The program aims to test a key magnetic anomaly adjacent to Victory Metals’ North Stanmore REE deposit.

Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.

West Cobar Metals is set to begin a 5,000-metre air core drilling campaign at its Mystique gold project in Western Australia, following key approvals and strong nearby gold intercepts that hint at significant mineral potential.